PWP vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

PWP

46.4
AI Score
VS
HIVE Wins

HIVE

48.2
AI Score

Investment Advisor Scores

PWP

46score
Recommendation
HOLD

HIVE

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PWP HIVE Winner
Revenue 305.44M 79.12M PWP
Net Income 6.79M -142.91M PWP
Net Margin 2.2% -180.6% PWP
ROE -14.8% -33.8% PWP
ROA 1.1% -15.5% PWP
Total Assets 644.97M 924.64M HIVE
Cash 115.85M 208.04M HIVE

Relative Price Performance (Last 90 Days)

PWP 1M: +11.0% · 3M: -9.6% HIVE 1M: -4.7% · 3M: -21.3%

Current Technical Phase

PWP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.0 · Price: $16.61

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.9 · Price: $3.03

Fundamentals Snapshot

Metric PWP HIVE
Market Cap
Forward P/E 10.9 -5.9
Trailing P/E 61.6
Revenue (TTM)
Revenue Growth 0.0% 0.7%
Gross Margin 1.0% 0.4%
Operating Margin 0.1% -0.6%
EPS 0.27 -1.54
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.